Apolipoprotein C-III gene variation and dyslipidaemia

Current Opinion in Lipidology

Volumn 8, Issue 3, 1997, Pages 154-158

  Talmud, Philippa J ^a   Humphries, Steve E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C3; DNA; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DNA FLANKING REGION; DNA POLYMORPHISM; DYSLIPIDEMIA; GENE CLUSTER; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HYPERTRIGLYCERIDEMIA; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MULTIGENE FAMILY; PROMOTER REGIONS (GENETICS); SEX CHARACTERISTICS; VARIATION (GENETICS);

EID: 0030878283     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199706000-00005     Document Type: Review

References (24)

1. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP: Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts; lipid and non-lipid factors. Circulation 1990, 81:470-476.
2. Krauss RM, Herbert PN, Levy RI, Fredrickson DS: Further observation on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res 1973, 33:403-411.
3. Windler E, Havel RJ: Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfursed rat liver. J Lipid Res 1985, 26:556-565.
4. Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, Gilligan M, Gambert P, Ball MJ: Variation at the apo AI-CIII-AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 1991, 87:239-247.
5. Bainton D, Miller NE, Bolton CH, Yarnell JW, Sweetnam PM, Baker IM, Lewis B, Elwood PC: Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Colloborative Heart Disease Studies. Br Heart J 1992, 68:60-66.
6. Aalto-Setälä K, Fisher EA, Chen X, Shaul TD, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg H, Breslow JL: Mechanism of hypertriglyceridemia in human apolipoprotein CIII transgenic mice. J Clin Invest 1992, 90:1889-1890.
7. Maeda N, Li H, Lee D, Oliver P, Quarfort SH, Osada J: Targeted disruption of the apolipoprotein CIII gene in mice results in hypotriglyceridaemia and protection from postprandial hypertriglyceridaemia. J Biol Chem 1995, 269:23610-23616. Homozygous deficient apoC-III mice have no detectable apoC-III protein or mRNA in liver or intestine, whereas apoA-I and A-IV are detected in the liver but reduced in the intestine. This suggests that the intestinal specific element is common to all three genes. Fasting TG levels are 70% of normal and there is no increase in TG after a fat meal.
8. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE: DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet 1983, 1:444-446.
9. Humphries SE, Peacock RE, Talmud PJ: The genetic determinants of plasma cholesterol and response to diet. In Clinical endocrinology and metabolism: international practise and research. Edited by Betteridge JB. London: Balliere Tindall; 1995:797-824.
10. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL: An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3 untranslated region polymorphism Proc Natl Acad Sci U S A 1993, 90:4562-4566.
11. Xu C-F, Talmud P, Humphries S: Three new polymorphisms of the apoAI-CIII-AIV gene cluster. Mol Cell Probes 1994, 8:331-332.
12. Omori K, Vergnes L, Zakin MM, Ochoa A: The apolipoprotein AI-CIII-AIV gene cluster: sequence of the ApoCIII-ApoAIV intergenic region. Gene 1995, 159:231-234. The complete sequence of the apoC-III A-IV intergenic region is presented. This 4 kb of sequence is invaluable for the study of transcription factors within this region and the search for polymorphic sites for association studies.
13. Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T: Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 1995, 96:2601-2605. In animals and cell lines apoC-III is downregulated by insulin and a negative IRE has been identified previously in the apoC-III promoter. Using CAT as a reporter gene, variation at any of five variant sites in the apoC-III promoter resulted in loss of response to insulin downregulation. The IRE was mapped to sites -455 and -482; however, only the -455 polymorphic site showed binding to a nuclear protein and this might be the critical site for insulin control.
14. Ginsburg GS, Satoshi N, Ginsberg H, Glickman RM: A common genetic variant upstream of the apoCIII gene coordinately controls intestinal expression of the human apoAI and apoAIV genes [Abstract]. Circulation 1996, 94:1-274, 1591. Endoscopic biopsies from 18 healthy individuals were used to study apoA-I and apoA-IV synthetic rates and mRNA levels; these were highly correlated. When these individuals were haplotyped for the five APOC-III promoter polymorphisms, the two resulting haplotypes were significantly associated with apoA-I and apoA-IV synthetic rates. The intestinal element for all three genes of the cluster might lie within this region of the APOC-III promoter.
15. Walsh A, Azrolan N, Wang K, Marcigliano A, O'Connell A, Breslow JL: Intestinal expression of the human apoAI gene in transgenic mice is controlled by a DNA region 3 to the gene in the promoter of the adjacent convergently transcribed apoCIII gene. J Lipid Res 1993, 34:617-623.
16. Bisaha JG, Simon TC, Gordon JI, Breslow JL: Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium. J Biol Chem 1995, 270:19979-19988. The intestinal expression enhancer of the human APOA-I C-III A-IV cluster was mapped to a region at -780 to -520 within the APOC-III promoter with cis-acting suppressors lying outside the region -1300 to - 200. Two specific 21-mers lying between - 745 to -725 and -700 to -680 bind nuclear proteins from intestinally derived cells. The 260 bp fragment was conserved in mouse apoC-III and is the first in-vivo system defining tissue-specific expression.
17. Surgochov AP, Page GP, Smith L, Patsch W, Boerwinkle E: Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridaemia. Arterioscler Thromb Vasc Biol 1996, 16:941-947. The association of a number of quantitative traits and the five apoC-III promoter polymorphisms and Sstl site was examined. The Sstl site alone was associated with hypertriglyceridaemia but not apoC-III level, carotid thickness or raised cholesterol. The 5′ variable sites had no effect on baseline lipid levels. Thus in the haplotype analysis the significant association with hypertriglyceridaemia was solely attributable to variation at the Sstl site.
18. Haviland MB, Kessling AM, Davignon J, Sing CF: Cladistic analysis of the apolipoprotein AI-CIII-AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis. Ann Hum Genet 1995, 59:211-231. Cladistic analysis identified three haplotypes defined by markers in the APOA-I C-III A-IV cluster that showed small effects on quantitative traits and gender-specific effects.
19. Mahaney MC, Blangero J, Rainwater DL, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW, Hixson JE: A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study. Segregation and linkage analyses. Arterioscler Thromb Vasc Biol 1995, 15:1730-1739. Although evidence of a major gene determining HDL-cholesterol levels could be identified by maximum-likelihood complex segregation analysis, none of the candidate genes (APOA-I, C-III, B, E, LDL-receptor, lipoprotein lipase, hepatic lipase) used in this study showed tight linkage and therefore no major gene could be identified from this group of candidates.
20. Hegele RA, Brunt JH, Connelly PW: Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol 1995, 15:861-871. The Hutterites represent an isolated community, very useful in genetic studies. Association with variable sites in nine candidate genes and plasma lipid levels was studied. Modest but statistically significant variation in lipid levels could be explained by variation in these candidate genes. Information is lost by analysing males and females together, thus gender-specific differences are not observed.
21. Bai H, Saku K, Liu R, Imamura M, Arakawa K: Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 1995, 95:102-104. This study found no difference in frequency of the S allele of the Sstl site in Japanese coronary heart disease patients and healthy control individuals The end point is a complex trait and the study might not have the power to detect a frequency difference.
22. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J: An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 1995, 95:371-375. In this Japanese study frequency of the APOC-II/ Sstl site and APOA-I Mspl site was compared in hypertiglyceridaemic patients and control individuals. A statistically significant difference was seen with both polymorphisms. This confirms frequency differences seen in Caucasian populations.
23. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ: Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 1996, 58:585-594. Linkage of the LDL-receptor gene to LDL particle size was confirmed in this linkage study of sib-pairs taken from CAD families. A number of other candidate genes were also studied. Tentative linkage to APOC-III, cholesteryl ester transfer protein and manganese superdismutase genes was shown.
24. Hasse A, Stoffel W: The 3′-flanking region shared by the human apolipoprotein AI and CIII gene regulates gene expression in cooperation with 5′-flanking elements. Biol Chem 1990, 371:375-382.